Chiropractors | Saltillo, MS – Chiropractic Neurology Center of Tupelo – Video

Posted on by


Chiropractors | Saltillo, MS - Chiropractic Neurology Center of Tupelo
The chiropractors at the Chiropractic Neurology Center of Tupelo treat fibromyalgia. If you #39;re suffering, Brain Based Therapy can be the solution. Visit us: ...

By: Chiropractic Neurology Center of Tupelo

Read more from the original source:
Chiropractors | Saltillo, MS - Chiropractic Neurology Center of Tupelo - Video

Neurology Research – UPMC Pittsburgh Clinical

Posted on by

The Department of Neurology has a sustained commitment to excellence in the three major components of academic medicine: teaching, clinical care and research that advances medical knowledge and therapy. Research funding for the clinical, basic, and translational studies in the department has increased steadily over the past few years and in FY2011 the department received $7,408,324 in NIH grant support.

Basic Research Basic scientists in the Department of Neurology continue to be successful in securing extramural funding. Several new extramural basic science grants were awarded to neurology faculty from July 1, 2010 to June 30, 2011. In addition, Neurology faculty received notice that several other awards will be funded in the coming fiscal year.

Basic neuro-science investigators in the Department of Neurology had a number of successes during the past academic year. Some of the major achievements include:

Clinical Research Clinical research in the Department of Neurology has also expanded in the last several years and significant numbers of patients with neurologic diseases are enrolled in ongoing clinical trials. This is an invaluable resource for continued development of research in the department, and also attracts patients to our medical center.

Training Grants

Michael Zigmond continued directing an NIMH T32 training grant focused on training in the neurobiology of psychiatry disorders and an NINDS T32 training grant to provide training in the neurobiology of neurodegenerative diseases. In addition, Dr. Zigmond continues to direct an NINDS U13 grant to conduct survival skills and ethics workshops for neuroscientists.

Visit link:
Neurology Research - UPMC Pittsburgh Clinical

Plot twist: Neurologist turns her hand to romance writing and grabs the prize – CBC.ca

Posted on by

There were always clues that aspiring novelist Dr. Anne Lipton would eventually immerse herselfinto the world of make-believe, fantasyand adventure.

"One of the things that I wrote about in my medical school essay was Nancy Drew," says Lipton, who lives in Vancouver.

"Nancy Drew ... inspired meto try to be a medical detective and find out what was going wrong when someone was sick and howto make them better."

Lipton, who is originally from Michigan,did end up becoming a "medical detective" and a pretty successful one to boot. The Northwestern University graduate became a neurologist, even penning multiple books on dementia care.

But now, her career has taken a plot twist.

Lipton is one of the inaugural recipients of the Harlequin Books Creator Fund Award, awarded to up-and-coming female writers in the U.S. and Canada.Harlequin, a Toronto-based publishing house, is one of the most successful publishers in the world, with a focus on romance, fantasyand historical fiction.

Romance writing, a genre sometimes dismissed as "empty entertainment", is big business. According to the Romance Writers of America, the billion-dollar romance genre makes up 23 per cent of the fiction market.

In recent years, the genre has undergone a feminist makeover, challenging archaic tropesof damsels in distress and other stereotypes.

Lipton'smanuscript a time travel Christmas-themed romantic comedysetin the video game industry is a nod to that.

"[My main character] isa strong female protagonist who works in a male-dominated industry," she said.

It was a move to Ireland that set the stage for Lipton's career change. Despite having a position ready, it was taking a long time for her medical credentials to be recognized in Ireland.

As she waited to be certified, Lipton, who had already written non-fiction, decided to try her hand at writinga novel.

She loved it.

Part of the process of novel writing mirrors her work as a neurologist. Lipton said she was drawn to neurology, and dementiain particular, because of her patients' rich life stories.

"Because dementia often affects older people I was able to hear many very exciting and interesting life stories," she said.

"I would say one reason I didn't go into something like emergency medicine is because once the patient leaves the emergency department you never hear the end of the story. And so I like to have a satisfying story arc in real life and in my novels."

A move to Vancouverseven years ago happened to coincide providentially with NaNoWriMo National Novel Writing Month in November.

Lipton, who happened to move in the month of October, said she almost immediately got together with other writers in the city.

The internet-based creative writing challenge gives participants exactly 30 days to write a draft of a book or novel, with a minimum 50,000 word count. Close to 10,000 people participate in the challenge across the country.

"I know sometimes people say that Vancouver is a hard place to meet people but I found this a great way to meet people. We all had a shared interest. Most of the people there also enjoyed reading so we discussed books and writing and it was a great way to meet people."

As part of her award, Liptonwill receive financial and editorial support from Harlequin but there are no guarantees her manuscript will get published.

"Asa writer, sometimes it's more competitive thanapplying to medical school in terms of trying to get published," she laughed.

In the meantime, she's hoping for a riveting finale.

See original here:
Plot twist: Neurologist turns her hand to romance writing and grabs the prize - CBC.ca

Neurology Journals | Peer Reviewed | High Impact Articles list

Posted on by

Neurology Journal is an official peer reviewed journal for the rapid publication of innovative research covering all aspects of neurology and its related disorders. Neurology Journal with highest impact factor offers Open Access option to meet the needs of authors and maximize article visibility.

Neurology Journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.

This peer reviewed journal is using Editorial Manager System for quality in review process. Editorial Manager System is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Neurological Disorders or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through this system.

Submit manuscript at http://editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at editor.jnd@omicsonline.org

Neurodegenerative Disorders are defined as hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral structures of the nervous system.

Related Journals of Neurodegenerative Disorders

Neuroinfectious Diseases,Multiple Sclerosis,Dementia & Mental health,Alzheimers Disease & Parkinsonism,Neurodegenerative Diseases, Neurodegeneration: A journal for neurodegenerative disorders, Neuroprotection, and Neuroregeneration, Molecular Neurodegeneration, Translational Neurodegeneration, Neurodegeneration

The topic includes the understanding and treatment of Neurodegenerative diseases. The study of Experimental neurology aims at the basic mechanisms involved in Neurological disorders and novel findings in neural development, regeneration, Plasticity and transplantation.

Related Journals of Experimental Neurology

Neurology & Neurophysiology,Neuroscience & Clinical Research,Clinical & Experimental Neuroimmunology,Neurology and Neuroscience,Journal of Neuropathology and Experimental Neurology, Experimental Neurology, Neuromuscular Disorders, Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders- Drug Targets

CNS and Neurological disorders are diseases that affect the brain and the central and autonomic nervous systems. In recognizing the signs and symptoms of neurological disorders, it is first important to distinguish the different types of neurological disorders.

Related Journals of CNS and Neurological Disorders

Neuroinfectious Diseases,Dementia & Mental health,Depression and Anxiety,Epilepsy Journal,CNS and Neurological Disorders- Drug Targets, CNS Neuroscience and Therapeutics, Current Drug Targets: CNS and Neurological Disorders, Therapeutic Advances in Neurological Disorders, Italian Journal of Neurological Sciences, American Association of Neurological Surgeons

A stroke occurs when the blood supply to part of your brain is interrupted or severely decreased, depriving brain tissue of oxygen and nutrients. Within minutes, brain cells begin to die. A stroke is a medical emergency. Stroke also broadly includes intracerebral hemorrhage and subarachnoid hemorrhage.

Related Journals of Stroke

Neurology & Neurophysiology,Neuroinfectious Diseases,International Journal of Pediatric Neurosciences,Clinical & Experimental Neuroimmunology,Experimental and Translational Stroke Medicine, Journal of Experimental Stroke and Translational Medicine, Journal of Stroke and Cerebrovascular Diseases, Stroke Research and Treatment, Topics in Stroke Rehabilitation, Translational Stroke Research, Canadian Council of Cardiovascular Nurses of the Heart and Stroke Foundation of Canada

Neurosugical Emergencies can be defined by certain criteria including rapidity of onset poor prognosis.It cares for undifferentiated, unscheduled patients with acute illnesses or injuries that require immediate medical attention. Neurosurgical emergency is one of the medical specialty concerned with the prevention, diagnosis, treatment, and rehabilitation of disorders which affect any portion of the nervous system including the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system.

Related Journals of Neurosurgical Emergencies

Family Medicine & Medical Science Research, Spine & Neurosurgery, Neurology and Neuroscience,Emergency Medicine: Open Access,Journal of Neurosurgery, Turkish Neurosurgery, Journal of Neurosurgery: Pediatrics, Neurosurgery, Neurosurgery Clinics of North America, Neurosurgery Quarterly, Open Neurosurgery Journal, Stereotactic and Functional Neurosurgery

Neurological Physiotherapy topic relates to the assessment and treatment of people with disorders of the nervous system. This includes conditions affecting the central nervous system, such as Stroke, Multiple Sclerosis and Motor Neuronal disorders. It also includes conditions affecting the peripheral nervous system, such as peripheral neuropathy.

Related Journals of Neurological Physiotherapy

Neurology & Neurophysiology,Psychology & Psychotherapy,Stroke Research & Therapy,Neuroscience & Clinical Research,Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders - Drug Targets, Current Drug Targets: CNS and Neurological Disorder, Neuromuscular Disorders

Parkinson's Disease is a central nervous system disorder. It mainly affects nervous systems. It inhibits the production of dopamine. Symptoms include muscle rigidity, tremors and change in speech. It doesnt have any cure, only relief can be provided with medications and surgery. Drugs that are used in treatment are levodopa, dopamine agonists (amomorphine, bromocriptine), MAO-B inhibitors and others like amantadine and anticholinergics.

Related Journals of Parkinson's Disease

Pediatric Neurology and Medicine,The Headache Journal,Neuropsychopharmacology & Mental Health,Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders- Drug Targets, Current Drug Targets: CNS and Neurological Disorders

It is a group of neurological disorders that are characterized by recurrent seizures. There are two types of epilepsy: idiopathic and symptomatic, which are sub divided into generalized, partial and petit mal seizures. Epilepsy is caused by genetics or it may be acquired. Management consists of first aid, medications, surgery, other and alternative medications. Medications include acetazolamide, carbamazepine, clonazepam, phenobarbital and phenytoin.

Related Journals of Epilepsy

Epilepsy Journal,Trauma & Treatment,Neurology & Neurophysiology,Neuroscience & Clinical Research,Epilepsy and Behavior, Epilepsy and Behavior Case Reports, Epilepsy and Seizure, Nihon Tenkan Gakkai/Japan Epilepsy Society, Epilepsy Currents, American Epilepsy Society, Epilepsy Research, Journal of Epilepsy

It is also known as convulsions. It is a change in behavior that occur after an episode of abnormal electrical activity in brain. It is caused by brain tumor, drug abuse, electric shock, epilepsy, fever and head injury. Seizure disorderare of generalized tonic-clonic, absence, myoclonic, clonic, tonic and atonic. Medications like carbamazepine, clobazam, clonazepam, ethosuximide, primidone, valproic acid and many more are used.

Related Journals of Seizure Disorder

Epilepsy Journal,Trauma & Treatment,Neurology & Neurophysiology,Neuroscience & Clinical Research,Epilepsy and Seizure, Seizure : The journal of the British Epilepsy Association, Epilepsy and Behavior, Epilepsy and Behavior Case Reports, Epilepsy Research, Journal of Epilepsy, Journal of Epilepsy and Clinical Neurophysiology

It is a term that includes many diseases that impair the functioning of muscles, either directly or indirectly. It causes directly by being pathologies of muscle and indirectly by being pathologies of nerves or neuromuscular junctions. Disorders are Amyotrophic lateral sclerosis, Multiple sclerosis, Myasthenia gravis and Spinal muscular atrophy.

Related Journals of Neuromuscular Disorders

Bipolar Disorder: Open Access,Dementia & Mental Health, Spine & Neurosugery, Spine,Neuromuscular Disorders, Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders - Drug Targets

It is also known to be manic depression. This causes extreme mood swings that include emotional highs (mania) and emotional lows (depression). These are divide into Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder and Other types. It is caused by biological difference, neurotransmitters and inherited traits. Medications include mood stabilizers (valproic acid, carbazepine), antipsychotics (lurasidone, ziprasidone), antidepressants and anti-anxiety like benzodiazepines.

Related Journals of Bipolar Affective Disorders

Bipolar Disorder: Open Access,Neuroinfectious Diseases,Dementia & Mental Health,Depression and Anxiety,Bipolar Disorders, Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders- Drug Targets, Current Drug Targets: CNS and Neurological Disorders

It is a disease or dysfunction of nerves usually peripheral nerves as opposed to central nervous system. It depends on the nerves that are affected. They are many causes like diabetes, drugs, poisions, cancers, excess alcohol, chronic liver and kidney diseases and infections. Drugs prescribed are gabapentin, carbamazepine, duloxetine, nortriptyline, desipramine and oxycodone.

Related Journals of Neuropathy

Psychology & Psychotherapy, Stroke Research & Therapy,Neuropsychopharmacology & Mental Health, Neuropsychiatry,Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders- Drug Targets, Current Drug Targets: CNS and Neurological Disorders

It is an inflammatory disease of brain and spinal cord where the insulating covers of nerve cells are damaged. It is an autoimmune disorder that affects the central nervous system. It may be caused by geography, genetics, infectious agents and others. Symptoms include weakness, tingling, numbness and blurred vision. Drugs that are used for treatment are interferon beta-1a (Avonex, Rebif), peginterferon beta-1a (Plegridy), teriflunomide (Aubagio), fingolimod (Gilenya), mitoxantrone (Novantrone), dimethyl fumarate (Tecfidera) and natalizumab (Tysabri).

Related Journals of Multiple Sclerosis

Spine,Spine & Neurosurgery,Clinical & Experimental Neuroimmunology,Neuroinfectious Diseases,Multiple Sclerosis, Multiple Sclerosis and Related Disorders, Consortium of Multiple Sclerosis Centers (CMSC), Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders- Drug Targets, Current Drug Targets: CNS and Neurological Disorders

It is a group of permanent movement disorders that appear in childhood. Symptoms include poor coordination, stiff muscles, weak muscles, trouble speaking and tremors. There are many complications like muscle weakness, muscle spasticity and coordination problems. Treatment requires long term care with medications. Medications include onabotulinum toxinA injection, diazepam, dantrolene, baclofen. Therapies and surgeries are also given.

Related Journals of Cerebral Palsy

International Journal of Pediatric Neurosciences,Pediatric Neurology and Medicine,Trauma & Treatment,Epilepsy Journal,Neuromuscular Disorders, Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders- Drug Targets, Neurosurgery Quarterly, Open Neurosurgery Journal

It is a bacterial illness. It is caused by bacterium spirochete and spreads by tick bites. It starts in the place of bite and expands by forming a ring of redness. It is diagnosed by clinical signs and detection of antibodies to causative bacteria. It causes abnormalities in skin, joints, heart and nervous systems. It is treated with antibiotics and doxycycline is contraindicated in children and pregnant women, so alternatives like amoxicillin and azithromycin are given.

Related Journals of Lyme

Neuroinfectious Diseases,Autism-Open Access,Neurooncology: Open Access,Acta Psychopathologica,Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders- Drug Targets, Current Drug Targets: CNS and Neurological Disorders, Multiple Sclerosis, Journal of Neurosurgery

It is defined as Attention deficit hyperactivity disorder. It is a neurological psychiatric disorder. It causes significant problems with attentional and inhibitory control that causes attention deficits, hyperactivity or impulsiveness. Symptoms begin by age six to twelve and persist for more than six months for a diagnosis to be made. The cause of most cases is unknown; however, it is believed to involve interactions between genetic and environmental factors and society. ADHD management usually involves some combination of counseling, lifestyle changes, and medications. Medications are stimulant and non-stimulant. Stimulant medications are amphetamine, dextroamphetamine and non-stimulant medications are atomoxetine and clonidine.

Related Journals of ADHD

Neuropsychiatry,Psychology & Psychotherapy,Acta Psychopathologica,Neurology and Neuroscience,ADHD Attention Deficit and Hyperactivity Disorders, Bipolar Disorders, Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders - Drug Targets, Current Drug Targets: CNS and Neurological Disorders

OMICS International Organises 1000 Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members and 10 millon readers all over the world .

Journal of Neurological Disorders is associated with our international conference 5th World Congress on Neurology and Therapeutics during March 14-16, 2016 London, UK exploring the Challenges and Recent Innovations in Neurology and Therapeutics. We are particularly interested in the areas of Neurological Disorders: An Over view, Causes: Origin, Genesis and Source, Brain Disorder, Manifestation, Pathophysiology, Brain Disorder: Anticipatory Measure and Pervasiveness. We encourage articles involving Parkinson, cerebral palsy, epilepsy, EEG, Neuropathy, muscular dystrophy, peripheral neuropathy, neuromuscular disorders.

Read the original:
Neurology Journals | Peer Reviewed | High Impact Articles list

What Is a Neurologist? – Brain and Nerve Tests …

Posted on by

Neurologist Education and Training

A neurologist is a medical doctor or osteopath who has trained in the diagnosis and treatment of nervous system disorders, including diseases of the brain, spinal cord, nerves and muscles.

Neurologists perform neurological examinations of the nerves of the head and neck; muscle strength and movement; balance, ambulation, and reflexes; and sensation, memory, speech, language, and other cognitive abilities.

They also perform diagnostic tests such as the following:

To become a board-certified neurologist several requirements must be met.

Residency programs accredited by the Accreditation Council for Graduate Medical Education (ACGME) provide supervised experience in hospital and ambulatory care settings as well as educational conferences and research trainings.

After completing residency training, neurologists may enroll in a fellowship program to develop expertise in a subspecialty such as stroke, dementia or movement disorders.

After completing the educational requirements, medical doctors may seek certification from the American Board of Psychiatry and Neurology (ABPN), a member of the American Board of Medical Specialties (ABMS).

Additional certification is offered in the following fields:

To be eligible, applicants must:

Certification by the American Board of Osteopathic Neurologists and Psychiatrists requires a high degree of competency in the practice of neurology at the time of certification.

To be eligible for board certification, applicants must:

Publication Review By: Stanley J. Swierzewski, III, M.D.

Published: 31 Dec 1999

Last Modified: 02 Sep 2015

See the original post:
What Is a Neurologist? - Brain and Nerve Tests ...

Neurology – St. Joseph

Posted on by

St. Joseph Neurology is now a Provider-Based Clinic. Learn more here.

St. Joseph Neurology has locations in College Station and Bryan. We offer a neurology practice specializing in diagnosis and treatment of neurological conditions while providing quality, comprehensive and compassionate care. Our neurologist staff includes:

Our team specializes in areas including, but not limited to:

If you're experiencing severe pain from a surgery, illness or injury, you could be referred to a Pain Management physician.

Pain Management services treat patients with:

Neurologists also manage long-term care for patients with:

A referral is usually required from a family or attending physician for long-term care.

At St. Joseph Neurology we believe in an individualized approach to patient care, and will do our best to make your visit with us as comfortable as possible. We encourage you to ask questions and are committed to keep you informed about your options for treatment. We realize that our patients are the reason we exist and we strive to treat every patient professionally with reverence, service and stewardship.

St. Joseph Neurology accepts Medicare and most major health insurance plans.

4421 State Hwy. 6 South College Station, TX 77845 979.690.4470 Office Hours: Monday - Friday

View Larger Map

2700 E. 29th Street, Ste. 305 Bryan, TX 77802 979-690-4825 Office Hours: Monday - Friday

See the original post:
Neurology - St. Joseph

National Institute of Neurological Disorders and Stroke …

Posted on by

New Award Creates Stable Funding for Outstanding Neuroscience Investigators

As NINDS Director, my goal is to optimize the progress of basic, translational, and clinical neuroscience research. One issue that slows the pace of discovery is that, rather than directly engaging in research, many principal investigators spend a great deal of their time writing and administering grant proposals. This is a consequence not only of the current constrained budget climate, but also of the fact that NIH grants fund individual projects that are relatively short in duration.

We feel that it is time to free up smart, talented people with innovative ideas to focus their time and effort on doing excellent science. To empower investigators to use their time more productively, NINDS is piloting a new funding mechanism the Research Program Award (RPA). Rather than funding a single project, an RPA will support an NINDS investigators overall research program for up to eight years. This initial pilot program aims to fund up to 30 investigators in FY 2016 who have demonstrated strong potential to do high impact science. The announcement describing this new award was released July 15 for an application deadline of Oct 6. For further information about the RPA, see the blog post from our Extramural Director Robert Finkelstein.

Go here to see the original:
National Institute of Neurological Disorders and Stroke ...

Neurology at the University of Pittsburgh

Posted on by

Department News

McCandless woman 1st in region with implant aimed at halting seizures.

Blockbuster or Bust? Brain Waves May Predict Movie Success.

Dementia Expert Invited to Attend Young Leaders in Dementia Event at British Embassy

Eric McDade, DO, assistant professor in the University of Pittsburgh Department of Neurology, has been invited to attend the U.S. Young Leaders Discussion Series for Innovative Ideas to Address Dementia at the British Embassy in Washington, D.C.

Think Like a Doctor: Losing It.

3 health solutions come out on top in Pitt competition.

University of Pittsburgh Comprehensive Epilepsy Center (UPCEC) - that includes the Adult (PUH/LKB) and Pediatric (CHP) Epilepsy Divisions - reached an important milestone: 50 resective surgeries in 2013.

This places us in the group of most productive epilepsy centers in the Country. In fact, when compared with the most recent available data from the National Association of Epilepsy Centers (NAEC) from 2012, with our 50 resections in 2013, the UPCEC would be the 3rd most productive epilepsy center among 190 NAEC members.

We would like to thank both our hospitals for their support and resources, our leaderships for their encouragement, and primarily to our meticulous and eager neurosurgeons and compassionate and dedicated large epilepsy teams that include the EMU technologists, nurses, epileptologists and neuropsychologists in CHP and PUH - for sustained 24/7 efforts that ultimately made this success possible.

It is our hope that sustain level of support and encouragement will kindle even more creative synergy among and within our teams that will lead not only to an even higher clinical productivity but also to more and diverse epilepsy research.

Pitt to be part of network to prevent, treat strokes

The University of Pittsburgh will participate in a network of 25 regional stroke centers assembled to advance and streamline research on stroke prevention, treatment and recovery, the National Institutes of Health announced on Friday.

"This network represents a new and innovative approach to finding more effective methods to prevent and treat strokes," said Dr. Lawrence Wechsler, professor and chair of the Department of Neurology at Pitt's School of Medicine and founder of the UPMC Stroke Institute.

Pitt, which is working in coordination with the UPMC Stroke Institute, is the only network site in Western Pennsylvania.

The National Institute of Neurological Disorders and Stroke will coordinate and finance the network.

The regional stroke centers will receive $200,000 for research costs and $50,000 for training stroke-clinical researchers per year over the first three years.

"NIH StrokeNet will allow the most promising therapies to quickly advance to the clinic, to improve prevention, acute treatment, or rehabilitation of the stroke patient," said Dr. Walter J. Koroshetz, deputy director of the institute.

"You walk into a room and forget why you entered in the first place..."

Dr. Robert Sweet was interviewed in the December 2nd Herald-Standard article "Senior moments or something more?"

A Life Hijacked: Alzheimer's 'insidious' slide

A November 30th Pittsburgh Post Gazette article that illustrates the challenges both patients and families face in the struggle with Alzheimer's. The Department of Neurology's Dr. Lopez is featured.

Michael Zigmond was named an honorary member of the Indian Academy of Neuroscience (IAN) at its annual meeting in Allahabad, India, in October, 2013. The IAN has awarded honorary membership to about two dozen individuals since its inception in 1982.

Dr. Zigmond, who gave a plenary lecture at the meeting on his research relating exercise and neurotrophic factors to neuroprotection in models of Parkinson's disease, has been lecturing widely in developing countries for more than 20 years. The lectures include reviews of his research, as well as material related to professional development and the responsible conduct of science. Zigmond has received two other awards for these activities, the Order of the Lion from Senegal and an International Distinguished Professorship from the government of China.

Pennsylvania Neurological Society had its successful 7th Annual Meeting in combination with Abington Memorial Hospital, and the International Conference of Interventional Neurology. The meeting was attended by more than 200 physicians from all over the world.

PNS had organized education programs by distinguished faculty who were recognized Nationally and regionally in Dementia, Stroke, Clinical Neurophysiology, and Legislative affairs, all of them were well received. The student, resident and fellows section had overwhelming participation in the research section by submitting abstracts at the meeting. Dr Balaji Krishnaiah (PGY-1), Neurology Resident , Department of Neurology, Penn State Medical Center received the best abstract award.

PNS elected its Board Members and officers for the 2013-2015 as per our Bylaws. Dr Parthasarathy Thirumala was elected President, Dr Micheal Mazowicki was elected Vice President, and Dr Matt Wicklund was elected Secretary.

PNS represents 750 Neurologists and more than 250 Residents, and Fellows in the state of Pennsylvania with a mission to "Improve the science and practice of neurology in Pennsylvania via: Education, Advocacy and Exchange of ideas amongst neurologists".

Comprehensive Stroke Center certification

On behalf of the UPMC Stroke Institute, we wanted to express our thanks to all who were involved in the preparations, day of survey activities, and post survey work.

Please share this exciting news with your staff who have worked so hard to achieve this. Without their dedication to providing the highest level of care, it would not have been possible.

We will be collecting data for the next 4 months on several areas that were identified during the survey.

New York Times Article Predicts Lucrative Future for Health Care Data Industry On February 19 an article by Julie Creswell "A Digital Shift on Health Data Swells Profits in an Industry" appeared in the New York Times describing a lucrative future for Digital Health Care Data companies in the wake of recent legislation. The Department of Nuerology's Dr. Vivek Reddy is featured.

Sasa Zivkovic Interviewed on KDKA Sasa Zivkovic was interviewed by Maria simbra on KDKA and broadcast on 12/31 re veterans with ALS. More...

SOCIETY FOR NEUROSCIENCE ANNOUNCES ACHIEVEMENT AWARDS - 10/13/2012 Awards recognize contributions to early promise, career achievement, and the advancement of women

NEW ORLEANS The Society for Neuroscience (SfN) announced the winners of major achievement awards during Neuroscience 2012, SfNs annual meeting and the worlds largest source of emerging news about brain science and health.

Achievement awards offer the neuroscience community the opportunity to recognize the promise of early career scientists, the accomplishments of senior researchers, and the important role of mentorship in promoting the professional advancement of women in neuroscience, said Moses V. Chao, PhD, president of SfN.

Mika Salpeter Lifetime Achievement Award: Michael Zigmond, PhD Established in 2000, the Mika Salpeter Award recognizes individuals with outstanding career achievements in neuroscience who have also actively promoted the professional advancement of women in neuroscience. The award includes a $5,000 prize.

Michael Zigmond, PhD, is a professor in the Department of Neurology at the University of Pittsburgh. Zigmonds research using cellular and animal models of Parkinsons disease has helped to reveal the intricacies of the relationship between stress, exercise, and trophic factors on the survival of dopamine neurons. He is particularly interested in the strategies dopamine neurons use to reduce their vulnerability to intracellular stress. Zigmond earned his PhD in 1968 from the University of Chicago.

Zigmond is also well known for his Survival Skills and Ethics workshops and publications, which offer professional skill development and ethical issue training for early career scientists. Through these workshops and extensive mentoring activities, he has encouraged many female scientists who have gone on to lead distinguished careers in neuroscience.

AAN Grassroots Alliance Spotlight: Pennsylvania member standing up against audiologists Pittsburgh neurologist Partha Thirumala, MD is learning (and showing) that a few phone calls can go a long way.

A bill in the Pennsylvania State Senate (SB 1352), titled the Speech-Language and Hearing Act, would expand the scope of audiology and allow them to perform Intraoperative Monitoring. When the bill started moving forward Dr. Thirumala took the initiative to contact and educate legislators and legislative staff on this broad skill set as well as the dangers that occur if they are performed insufficiently.

Thankfully the PA legislature came to an end without final passage of this legislation. However this bill will most certainly come up again in 2013. Thanks to Dr. Thirumalas educational and relationship building efforts neurology is in a good position to getour concerns addressed.

WPXI Story on Telemedicine Dr. Valerie Suski appeared on WPXI news on October 8, 2012. She told about the new technology that allows UPMC doctors in the Department of Neurology to deliver healthcare to patients anywhere. Dr. Lawrence Wechsler, Chairman, Department of Neurology, also spoke on the advantage of this new technology. You can track the story about telemedicine here.

ABEM Congratulates New Diplomat The American Board of Electrodiagnostic Medicine (ABEM)is pleased to announce that Ahmed M. El-Dokla, MD has successfully passed the 2012 Certification Examination and is now recognized a board-certified physician in electrodiagnostic medicine, which is the medical subspecialty that applies neurophysiologic techniques to diagnose, evaluate, and treat patients with impairments of the neurologic, neuromuscular, and/or muscular systems. Dr. El-Dokla finished in the top 10%.

Multiple Sclerosis Research Institute The Department of Neurology is pleased to announce it is now home to the Pittsburgh Institute forMultiple Sclerosis Care and Research. The core of the center is located in the newly remodeled Department of Neurology on the 8th floor of the Kaufmann Medical Building. The center has been recognized by the National MS Society (NMSS) as a comprehensive care center and works closely with the NMSS and many departments at UPMC and Pitt to collaborate in both care and research of multiple sclerosis and related disorders. The Institute boasts a state-of-the-art infusion center and a staff dedicated to improving the health and function of people with multiple sclerosis.Over 2000 patients currently receive care through this expanding program. The center is involved in multicenter trials of novel agents to control multiple sclerosis and collaborates in research with the UPMC departments of Gastroenterology, Urology, Physical Medicine and Rehabilitation, Childrens Hospital white matter disorders clinic as well as the University of Pittsburgh department of Human Genetics.

PARKINSONS ACTION NETWORK AWARDS $12,500 TO UNIVERSITY OF PITTSBURGH POSTDOCTORAL SCHOLAR AND RESEARCHER-ADVOCATE, LAURIE SANDERS, PH.D. GREENAMYRE LAB, UNIVERSITY OF PITTSBURGH

WASHINGTON, D.C.; AUGUST 8, 2012 The Parkinsons Action Network (PAN) announced today that Laurie Sanders, Ph.D., is the recipient of aParkinsons Action Network Postdoctoral Advocacy Prize, supported byTeva Pharmaceuticals.The Parkinsons Action Network (PAN) established this prize as part of an effort to recognize members of the scientific community for their advocacy and community outreach work.

Sandersserves as a leader in PANs grassroots advocacy program and reaches out to her Senators and Representative about issues important to the Parkinsons community. She has spoken to local Pittsburgh-area support group meetings and regularly does community outreach to help educate the general public about Parkinsons disease and the need for federal research funding. Not only does she incorporate her advocacy experiences in the courses she teaches, she also works within the university to encourage other postdoctoral researchers to make advocacy and public outreach an integral component of their work.

PAN believes Sanders is helping pioneer a whole new level of advocacy and engagement on behalf of the Parkinsons community.

This prize is not about rewarding promising research, but rather, commending scientific researchers for the important role they play in the fight for federal funding and policy support for the 500,000 to 1.5 million Americans living with Parkinsons disease, said Parkinsons Action NetworkCEO Amy Comstock Rick. In our advocacy work here in Washington, D.C., weve learned that researchers working in the lab and with patients bring a unique perspective and powerful voice to discussions with policymakers. We hope this prize encourages more researchers like Laurie to participate in advocacy and community outreach efforts because, almost more than anyone else, they understand the critical role of NIH and other federal funding at their universities and institutions, Rick added.

"PAN brings the scientific community and patients together so that both sides have a better understanding of one another -- and for many researchers, doing advocacy and outreach work is the first time they actually meet people with the disease they're researching," said Kevin Wilson, Director of Public Policy for the American Society for Cell Biology. "This prize is the most significant single effort I've ever seen in breaking down the silos and encouraging the scientific community to work with patient groups to educate around why research funding is so important," Wilson added.

The Parkinsons Action Network Postdoctoral Advocacy Prizewill be presented at PANs annual Morris K. Udall Awards Dinner in Washington, D.C., on October 3, 2012.

About the Parkinsons Action Network The Parkinsons Action Network is the unified voice of the Parkinsons community advocating for better treatments and a cure. In partnership with other Parkinsons organizations and its powerful grassroots network, PAN educates the public and government leaders on better policies for research and an improved quality of life for people living with Parkinsons. For more information about PAN, go to parkinsonsaction.org. # # #

Media Contact: Carol Blymire, Director of Communications cblymire@parkinsonsaction.org 202.638.4101 x113 (office) 301.332.8090 (cell)

Zigmond Featured in Neurology Today Michael Zigmond, PhD, Professor of Neurology, has studied the protective effects that exercise might provide against Parkinsons disease as well as other means of neuroprotection. A new article in Neurology Today focuses on animal models of exercise and its possible neuroprotective benefit for patients with PD. The entire article can be accessed here. (6/2012)

Massaro wins Excellence Award Lori Massaro, CRNP, Clinical Supervisor of the UPMC Stroke Institute, has received the American Heart Associations Great Rivers Affiliate Award of Excellence, the highest award given within the Great Rivers Affiliate. It honors an individual for exceptional and outstanding contributions to the advancement of the AHAs mission of building healthier lives, free of cardiovascular diseases and stroke in Delaware, Kentucky, Ohio, Pennsylvania, and West Virginia. The award, officially called the Lynn Smaha Award of Excellence, was named in honor of a passionate and pioneering physician and AHA volunteer who died in 2006. Lori received her recognition on June 14th (6/2012).

McAlister wins Mientus Award Jennifer McAlister, Patient Service Coordinator for the Department of Neurology, has been selected as a 2012 winner of the Robert Mientus Award for Staff Excellence in Service to the UPMC Physician Services Division, the highest award the PSD grants for service to the Physician Services Division. The award is named for a much respected senior human resources director who died unexpectedly and whose example is the inspiration for the award. Jennifer and two other award recipients will be honored at the Employee Recognition Luncheon on June 13 at the University Club. Her name will also be added to a permanent plaque in the Physician Services Division's corporate offices honoring previous recipients. (4/2012)

Zigmond Interviewed for Washington Post Article Michael Zigmond, PhD, Professor of Neurology was recently interviewed for an article in the Washington Post about the emerging evidence of the benefits of exercise for people with Parkinsons disease. Read the whole article here. (1/2012)

PIND Designated as United Way Agency The Pittsburgh Institute for Neurodegenerative Diseases (PIND) has been designated a United Way agency for donations. The mission of the PIND is to transform cutting-edge science into novel therapies and diagnostics that directly benefit individuals affected by neurodegenerative diseases, such as Parkinsons, Alzheimers, Huntingtons, ALS and other movement disorders. Please consider giving a gift to PIND through the United Way or making a donation in memory of or in honor of someone who has been touched by these terrible diseases. For your convenience, you can now make your gift online by visiting: http://www.unitedwaypittsburgh.org. Once registered, you can select Agency #10536316 for donations to go to PIND research. If you prefer, you can write a check to PIND by clicking here for information. Thank you for your support.

Zigmond to Co-Direct New Pitt Center Michael Zigmond, PhD, Professor of Neurology, Psychiatry and Behavioral and Community Health Sciences will co-direct the newly formed Center for Health Equity of the University of Pittsburgh Graduate School of Public Health with Dr. Angela Ford of the GSPH. The new undertaking aims to understand and reduce health disparities in underserved populations, particularly those in western Pennsylvania. Read the whole article here. (1/2012)

For past news items, visit our News Archive.

Read more from the original source:
Neurology at the University of Pittsburgh

Gadolinium the new problem – Neurology – MedHelp

Posted on by

I have been having pain right after a series of MRI contrast. Every other test has been clear. I have been pushed about as if I am crazy. Is it that every authority on the subject of MRI's and gadolinium regurgitate what has been written. Has the medical community completely shut off their cognitive reasoning.

Yes it is true gadolinium is non-radioactive. But that does not mean it is safe. Gadolinium is a lanthanide. It is a heavy metal. It has a few properties when its temperature changes and when exposed to magnetic waves. It has to be chelated when injected into the body. Why? BECAUSE IT IS TOXIC in its free state. Mercury, lead... heavy metals as well.

Chelate is when the a bond is created between 2 things. Your body chelates iron in your blood. It removes things by chelating. There are chemicals that when added to things can make them somewhat safer. DTPH-gd3 or something like that is gadolinium with DTPH. The DTPH chelates to the gadolinium and makes it soluable in water and keeps it under wraps. It flows in your blood and creates outlines that are viable when exposed to magnetic waves.

Here is a FACT. Some people suffer from a rare condition that when given gadolinium their calcium levels drop. This is because the bond created with the DTPH prefers things like calcium and zinc. When it drops the gadolinium for these other metals you know have free gadolinium. Everyone no matter who will have a certain level of this problem. And consider that not every batch of the chemical is perfect. People with kidney problems are unable to remove the gadolinium quickly. DTPH-gd3 have a half-life of 2~3 hours, which means that in that time 1/2 of the gadolinium is removed from the body. The bond in Omniscan and the like is not really stable and breaks down quickly. This means that if you are unable to remove the toxin in a certain time, the greater your chances of having more free gadolinium in your system.

I was fine till after the MRI's contrast. I keep hearing the same thing. Just because the FDA says one thing and that it has been used since 1988 and on millions of people means absolutely little. The ADA still says mercury fillings are great, and they make 5 million in royalties every year dispite the younger generations of dentists who refuse to use it and all the evidence to the contrary. I could go on, but because it is prolific does not mean it is 100% safe.

People have different levels of tolerance. People with good kidneys remove the waste rapidly, however, some will de-chelate. You will get some in your system.

I know the literature I have read it. I have talked to "professionals" but no one can answer me intelligently. The companies that produce these drugs make money. It does not benefit them to start a discourse on its possible failures. I am an econometrician. I understand statistics. The tests done can be made to say anything. Depends on what you leave out.

Fact gadolinium is a heavy metal

Fact It must be chelated to be put into the body

Fact I can de-chelate and will do over time.

See original here:
Gadolinium the new problem - Neurology - MedHelp

body burning – Neurology – MedHelp

Posted on by

When you had your IVF, did you have a reaction to the drugs? I too have had a lot of the same symptoms, especially the on and off joint pain, weakness mostly on left side, eye blurriness and a freakish jitter of the eyes when reading. As some one else posted, I am an avid reader and this is probably the most annoying symptom for me as it doesn't go away. Until 6 am this morning when I woke up with the side I was lying on feeling like I was burning up. Changed sides, back front, whichever I am lying on burns the most and makes the bed super hot.

I have seen all kinds of doctors including neurologist and have had every test you can think of. I show an auto immune deficiency, but nothing they can pin down. You stop asking the doctors since they start thinking you are faking it. Even my psychologist wondered and I have been seeing her 8 years since great cancer (genetic) and a hysterectomy due to fibroids and overly large ovaries (the doctor's term) being military growing up and then active duty and dual military I have lived everywhere including Guam, Germany, England, Japan and most states. No one has been able to pin it down, but after trial and error my psychologist and I figured out the right combo of drugs for depression and bi polar. Still heat, extreme cold, stress or even a minor illness can trigger symptoms, as can excessive stress. I came off lorazapam and take a small dose of diazapam and it helps. Then this morning I wake up with this terrible burning.

back to my original question, I had IVF through the military 20 years ago after my second eptopic pregnancy. I already had a son born between the two, so staying pregnant wasn't the issue, I just had no tubes. The initial hormone shots sucked big time, but it was not until I got pregnant (I insisted no more than 3 eggs against the doctors persistent recommendations). My overies produced 40 eggs which is almost unheard of. However, from two weeks on (they are very keen to see how it goes and I can't even tell you how many ultrasounds you get for this unless you have had it done, them you know) my ovaries kept getting larger and larger. I looked nine months pregnant from the beginning and almost died. Apparently I was one of the "25%" this happens too. Although I have beautiful twin daughters now 19, I have always said that all of those hormones and my reaction to them was going to be a problem latter on. I thought the hysterectomy resolved that, but after seeing that you had IVF also,I wonder if the nerve damage and autoimmune deficiency might be related to that. I have never once connected them until now. I will mention it to my doctor today as he burning is unbearable and I have to see him even if he can't help.

has any other woman had IVF over the years and are now experiencing nerve and joint issues? I am on three forums for this pain and now the burning. Despite the wonderful outcome, maybe messing with Mother Nature isn't such a good idea.

I realize it has been 3 years since your post, but perhaps someone can have some answers. Doctors don't.

Read the original:
body burning - Neurology - MedHelp